Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?

References

• Kiernan MC, Vucic S, Cheah B, Turner MR, Eisen A, Hardiman O, . Amyotrophic Lateral Sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Renton Alan E, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, . A Hexanucleotide Repeat Expansion in C9ORF72 is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie Ian R, Boeve Bradley F, Boxer Adam L, Baker M, Rutherford Nicola J, . Expanded GGGGCC Hexanucleotide Repeat in Non-coding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65 (Suppl 1):S3–9.
   Google Scholar
• Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805–11.
   PubMed Web of Science ®Google Scholar
• Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve. 1993;16:864–9.
   PubMed Web of Science ®Google Scholar
• Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 1992;15:219–24.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, . Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. AnnNeurol. 1990;28:18–25.
   Google Scholar
• Cheah BC, Vucic S, Krishnan AV, Kiernan MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem. 2010;17:1942–1959.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. Glycine and its synaptic interactions: functional and clinical implications. Neurology. 2011;77: 677–83.
   PubMedGoogle Scholar
• Eccles JC. The Inhibitory Pathways of the Central Nervous System: Liverpool University Press, 1969.
   Google Scholar
• Kato M, Dobyns WB. X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, ‘interneuronopathy’. J Child Neurol. 2005;20:392–7.
   PubMed Web of Science ®Google Scholar
• Eisen A. Amyotrophic lateral sclerosi: evolutionary and other perspectives. Muscle Nerve. 2009;40:297–304.
   PubMed Web of Science ®Google Scholar
• Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol (Berl). 1993;86:55–64.
   PubMed Web of Science ®Google Scholar
• Maekawa S, Al-Sarraj S, Kibble M, Landau S, Parnavelas J, Cotter D, . Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain. 2004;127: 1237–51.
   PubMed Web of Science ®Google Scholar
• Petri S, Krampfl K, Hashemi F, Grothe C, Hori A, Dengler R, . Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol. 2003;62:1041–51.
   PubMed Web of Science ®Google Scholar
• Petri S, Kollewe K, Grothe C, Hori A, Dengler R, Bufler J, . GABA(A)-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients. J Neurol Sci. 2006;250:124–32.
   PubMed Web of Science ®Google Scholar
• Stephens B, Navarrete R, Guiloff RJ. Ubiquitin immunoreactivity in presumed spinal interneurons in motor neuron disease. Neuropathol Appl Neurobiol. 2001;27:352–61.
   PubMedGoogle Scholar
• Stephens B, Guiloff RJ, Navarrete R, Newman P, Nikhar N, Lewis P. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease: a morphometric study. J Neurol Sci. 2006;244:41–58.
   PubMed Web of Science ®Google Scholar
• Lorenzo LE, Barbe A, Portalier P, Fritschy JM, Bras H. Differential expression of GABAA and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons: possible implications for selective vulnerability of motoneurons. Eur J Neurosci. 2006;23:3161–70.
   PubMed Web of Science ®Google Scholar
• Yokota T, Yoshino A, Inaba A, Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61:596–600.
   PubMed Web of Science ®Google Scholar
• Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540–50.
   PubMed Web of Science ®Google Scholar
• Weber M, Eisen A, Stewart HG, Andersen PM. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A Cu/Zn superoxide dismutase mutation. Brain. 2000;123:1505–15.
   PubMed Web of Science ®Google Scholar
• Turner MR, Osei-Lah AD, Hammers A, Al Chalabi A, Shaw CE, Andersen PM, . Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol NeurosurgPsychiatry. 2005;76:1279–85.
   PubMed Web of Science ®Google Scholar
• Wittstock M, Wolters A, Benecke R. Transcallosal inhibition in amyotrophic lateral sclerosis. Clin Neurophysiol. 2007;118:301–7.
   PubMed Web of Science ®Google Scholar
• Wittstock M, Meister S, Walter U, Benecke R, Wolters A. Mirror movements in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:393–7.
   PubMed Web of Science ®Google Scholar
• Smith MC. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1960;23:269–82.
   PubMed Web of Science ®Google Scholar
• Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010;75:1645–52.
   PubMed Web of Science ®Google Scholar
• Jiang M, Schuster JE, Fu R, Siddique T, Heckman CJ. Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29:15031–8.
   PubMed Web of Science ®Google Scholar
• Chang Q, Martin LJ. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci. 2011 epub;31: 2815–27.
   PubMedGoogle Scholar
• Mazzocchio R, Rossi A. Role of Renshaw cells in amyotrophic lateral sclerosis. Muscle Nerve. 2010;41:441–3.
   PubMedGoogle Scholar
• Raynor EM, Shefner JM. Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology. 1994;44:2148–53.
   PubMed Web of Science ®Google Scholar
• Kew JJ, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RS, . Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain. 1993;116:655–80.
   PubMed Web of Science ®Google Scholar
• Lule D, Ludolph AC, Kassubek J. MRI-based functional neuroimaging in ALS: an update. Amyotroph Lateral Scler. 2009;10:258–68.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Richardson MP, Brooks DJ, Al Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain. 2000;123: 2289–96.
   PubMed Web of Science ®Google Scholar
• Turner MR, Hammers A, Al Chalabi A, Shaw CE, Andersen PM, Brooks DJ, . Distinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [11C]flumazenil PET. Brain. 2005;128:1323–9.
   PubMed Web of Science ®Google Scholar
• Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional MRI in amyotrophic lateral sclerosis. Brain. 2011 (epub).
   Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011 (epub).
   PubMed Web of Science ®Google Scholar
• Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ, Leigh PN, . Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study. Amyotroph Lateral Scler. 2008; 9:43–9.
   PubMed Web of Science ®Google Scholar
• Priori A, Oliviero A, Donati E, Callea L, Bertolasi L, Rothwell JC. Human handedness and asymmetry of the motor cortical silent period. Exp Brain Res. 1999;128:390–6.
   PubMed Web of Science ®Google Scholar
• Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, . Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010, epub.
   Google Scholar
• Landau WM, Clare MH. The plantar reflex in man, with special reference to some conditions where the extensor response is unexpectedly absent. Brain. 1959;82:321–55.
   PubMedGoogle Scholar
• Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011 epub;10:253–63.
   PubMedGoogle Scholar
• Norris FH Jr, Ks U, Sachais B, Carey M. Trial of baclofen in amyotrophic lateral sclerosis. Arch Neurol. 1979;36: 715–6.
   PubMedGoogle Scholar
• Miller RG, Moore D, Young LA, Armon C, Barohn RJ, Bromberg MB, . Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Western Amyotrophic Lateral Sclerosis Study Group. Neurology. 1996;47:1383–8.
   PubMed Web of Science ®Google Scholar
• Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8: 94–109.
   PubMed Web of Science ®Google Scholar
• Vivekananda U, Manjalay ZR, Ganesalingam J, Simms J, Shaw CE, Leigh PN, . Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry. 2011;82:635–7.
   PubMed Web of Science ®Google Scholar
• Zhu H, Edden RA, Ouwerkerk R, Barker PB. High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med. 2011;65:603–9.
   PubMed Web of Science ®Google Scholar
• Muthukumaraswamy SD, Edden RA, Jones DK, Swettenham JB, Singh KD. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci USA. 2009;106:8356–61.
   PubMedGoogle Scholar
• Mohammadi B, Kollewe K, Samii A, Krampfl K, Dengler R, Munte TF. Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol. 2009;217:147–53.
   PubMed Web of Science ®Google Scholar
• Kann O, Huchzermeyer C, Kovacs R, Wirtz S, Schuelke M. Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain. 2011 epub;134:345–58.
   PubMedGoogle Scholar
• Stepien AE, Arber S. Probing the locomotor conundrum: descending the ‘V’ interneuron ladder. Neuron. 2008;60:1–4.
   PubMedGoogle Scholar
• Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ, . Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171–8.
   PubMed Web of Science ®Google Scholar